Detalles de la búsqueda
1.
Revisiting the epidemiology of pertussis in Canada, 1924-2015: a literature review, evidence synthesis, and modeling study.
BMC Public Health
; 20(1): 1749, 2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33218317
2.
Incidence and economic burden of Clostridioides difficile infection in Ontario: a retrospective population-based study.
CMAJ Open
; 8(1): E16-E25, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001435
3.
The Clinical Burden of Clostridioides difficile in Ontario, Canada.
Open Forum Infect Dis
; 7(2): ofz523, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025524
4.
Humoral immunity 10â¯years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
Vaccine
; 36(17): 2282-2287, 2018 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29573876
5.
Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
PLoS One
; 13(6): e0197970, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29912887
6.
Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
Clin Vaccine Immunol
; 22(3): 282-90, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25540274
7.
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Pediatr Infect Dis J
; 33(1): 73-80, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24346596
8.
Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study.
Pediatr Infect Dis J
; 32(1): 54-61, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23241989
9.
Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: a randomized, controlled, open-label, multicenter study.
Vaccine
; 30(23): 3360-8, 2012 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22475857
Resultados
1 -
9
de 9
1
Próxima >
>>